PETVW

PetVivo Holdings Inc. Warrant

🇺🇸 United States·NASDAQ

🇺🇸·NASDAQ

Stock Price

$0.01-$0.02 (-83.00%)

May 21, 2026

52W High $0.1052W Low $0.01

Company Details

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraartic...

Leadership

John Lai

CEO, President & Director

Garry N. Lowenthal

Chief Financial Officer

John F. Dolan

General Counsel, Chief Business Development Officer & Secretary

Bryan Monninger

Vice President of Sales & Distributor Relations

Andrea Cranston

Vice President of Marketing

IPO Date

Aug 11, 2021

Website

www.petvivo.com

Key Metrics TTM

Revenue

$1M

+16.3% YoY

Net Income

-$10M

EPS (Diluted)

Free Cash Flow

-$7M

Revenue / Share

$0.03

Gross Margin

66.0%

Operating Margin

-735.9%

Net Margin

-893.3%

FCF Margin

-633.8%

P/S

P/E

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee